Trucode Gene Repair's Incubator/Accelerator Round

Trucode Gene Repair raised a round of funding on July 12, 2017. Investors include JLabs.

Trucode Gene Repair is a discovery-stage therapeutics company developing a systemically delivered, oligonucleotide-based approach to in vivo gene editing, with an indication in sickle-cell disease.…

Articles about Trucode Gene Repair's Incubator/Accelerator Round: